The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising advance. Unlike subcutaneous injections, this method offers a more convenient way to administer GLP-1 https://theoltyf278402.blogspothub.com/39761243/glp-1-patches-a-novel-approach-to-blood-sugar-control